REPL short interest
Replimune Group Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 23,128,025 |
|---|---|
| Change vs prior report | 373,428 (+1.6%) |
| Change over six months | +41.6% |
| Days to cover | 10.83 (sector: 3.78) |
| Average daily volume | 2,136,193 |
| Rank in Healthcare | #94 of 922 by days to cover |
REPL short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 23,128,025 | +1.6% | 10.83 | 2,136,193 |
| 2026-09-15 | 22,754,597 | -3.2% | 11.14 | 2,042,814 |
| 2026-08-31 | 23,519,650 | -5.4% | 8.86 | 2,654,209 |
| 2026-08-14 | 24,866,611 | -9.7% | 3.96 | 6,282,298 |
| 2026-07-31 | 27,540,626 | +16.4% | 3.26 | 8,449,526 |
| 2026-07-15 | 23,654,362 | -0.1% | 9.44 | 2,504,998 |
| 2026-06-30 | 23,666,879 | +3.4% | 6.37 | 3,717,912 |
| 2026-06-15 | 22,885,091 | -11.8% | 4.84 | 4,731,854 |
| 2026-05-29 | 25,954,343 | +9.7% | 2.94 | 8,826,729 |
| 2026-05-15 | 23,657,005 | +11.8% | 2.83 | 8,360,368 |
| 2026-04-30 | 21,157,892 | +14.8% | 2.64 | 8,023,861 |
| 2026-04-15 | 18,426,035 | +12.8% | 1.39 | 13,281,741 |
| 2026-03-31 | 16,335,211 | +0.7% | 10.48 | 1,558,287 |
| 2026-03-13 | 16,229,838 | +2.3% | 9.74 | 1,665,818 |
| 2026-02-27 | 15,870,235 | +2.2% | 12.21 | 1,300,048 |
| 2026-02-13 | 15,531,819 | +1.3% | 13.68 | 1,135,271 |
| 2026-01-30 | 15,337,756 | +6.5% | 9.80 | 1,564,534 |
| 2026-01-15 | 14,396,576 | +7.6% | 11.78 | 1,222,202 |
| 2025-12-31 | 13,384,737 | -9.3% | 10.64 | 1,258,111 |
| 2025-12-15 | 14,761,596 | -3.4% | 7.97 | 1,852,025 |
| 2025-11-28 | 15,273,607 | -8.5% | 9.90 | 1,543,142 |
| 2025-11-14 | 16,697,152 | +3.7% | 6.04 | 2,764,511 |
| 2025-10-31 | 16,102,363 | -11.8% | 1.30 | 12,426,044 |
| 2025-10-15 | 18,250,390 | +2.0% | 6.24 | 2,924,904 |
| 2025-09-30 | 17,884,459 | +3.5% | 2.68 | 6,683,202 |
import finzdata as yf
yf.Ticker("REPL").short_interest # every report since 2017
yf.Client().short_interest(["REPL"], start="2018-01-01")Healthcare short interest · REPL price history · Who owns REPL · All short interest